Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Enrollment complete in Phase 2 study for drug targeting endocannabinoid system for IOP lowering
➤ Dosing complete for Phase 1/2 trial evaluating a gene therapy for Stargardt disease
➤ Pre-Phase 3 Type B meeting held with FDA by company focused on retinitis pigmentosa
➤ Updates from several late-stage clinical trials
➤ New company launches to pioneer nonviral gene therapies
➤ ASCRS news and events
➤ Study: artificial intelligence matches/outperforms ophthalmologists
➤ Primary endpoint met in Phase 3 trial using an antibody to treat thyroid eye disease
➤ FDA grants Breakthrough Device Designation to novel spectacle design
➤ ASCRS news and events
iCare HOME2 measuring IOP
Source: Thomas Johnson III, MD, PhD
Glaucoma specialists have now had the opportunity to come into the 21st century alongside some of the physicians in other medical specialties who have long used home monitoring devices to collect information on their patients’ conditions to better inform treatment.
➤ ASCRS advocacy helps protect MIGS coverage
➤ FDA approves generic loteprednol etabonate ophthalmic suspension
➤ Orphan Drug Designation granted for corneal endothelial cell substitute
➤ Positive results in Phase 2 clinical trial for contact lens discomfort
➤ First patient visits
➤ Acquisition news
➤ Complimentary access to video journal
➤ ASCRS news and events
Learning a variety of surgery techniques and clinical management approaches is important for surgeons in training. Physicians shared some of their personal experiences, including what they learned in training and since their training ending, and how these experiences have influenced them.
“As the year comes to a close, and before we start worrying about resolutions for the next one, we can all benefit by reflecting on where we are now in order to derive some lessons to carry forward,” said Glaucoma Editor Manjool Shah, MD, in his introduction to the section.
The pros of comanaging glaucoma patients with optometrists and keys to success are covered in this article.
➤ Primary, secondary endpoints met in Phase 2 wet AMD trial
➤ Modifications made to investigational glaucoma treatment device
➤ Positive Phase 1/2 data from clinical trial for treatment of Leber congenital amaurosis
➤ Results from first-in-human study of siRNA treatment for AMD
➤ Possibility of a minimally invasive approach for treating AMD
➤ ASCRS news and events
When performing cataract surgery in patients who have a functioning trabeculectomy, there may be an increased risk of trabeculectomy failure. Two physicians discussed this risk and how to approach these patients.
➤ First patient treated in Phase 2 study of investigational emulsion for glaucoma
➤ FDA issues complete response letter for dry eye drug NDA
➤ FDA meeting minutes issued for BLA submissions of ophthalmic formulation of bevacizumab
➤ Phase 1/2 trial to begin for first-in-class dry AMD therapy
➤ Company merger news
➤ ASCRS news and events
